These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29758248)

  • 1. Beneficial effect of etazolate on depression-like behavior and, learning, and memory impairment in a model of Parkinson's disease.
    Alzoubi KH; Mokhemer E; Abuirmeileh AN
    Behav Brain Res; 2018 Sep; 350():109-115. PubMed ID: 29758248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the protective effect of etazolate on memory impairment, anxiety- and depression-like behaviors induced by post traumatic stress disorder.
    Alzoubi KH; Al Subeh ZY; Khabour OF
    Brain Res Bull; 2017 Oct; 135():185-192. PubMed ID: 29107895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets for the interactive effect of etazolate during post-traumatic stress disorder: Role of oxidative stress, BDNF and histones.
    Alzoubi KH; Al Subeh ZY; Khabour OF
    Behav Brain Res; 2019 Sep; 369():111930. PubMed ID: 31047921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluvoxamine maleate effects on dopamine signaling in the prefrontal cortex of stressed Parkinsonian rats: Implications for learning and memory.
    Dallé E; Daniels WMU; Mabandla MV
    Brain Res Bull; 2017 Jun; 132():75-81. PubMed ID: 28549887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity.
    Sharma S; Taliyan R; Singh S
    Behav Brain Res; 2015 Sep; 291():306-314. PubMed ID: 26048426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sitagliptin rescues memory deficits in Parkinsonian rats via upregulating BDNF to prevent neuron and dendritic spine loss.
    Li J; Zhang S; Li C; Li M; Ma L
    Neurol Res; 2018 Sep; 40(9):736-743. PubMed ID: 29781786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrosative and cognitive effects of chronic L-DOPA administration in rats with intra-nigral 6-OHDA lesion.
    Ramírez-García G; Palafox-Sánchez V; Limón ID
    Neuroscience; 2015 Apr; 290():492-508. PubMed ID: 25644418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased synaptic plasticity in the medial prefrontal cortex underlies short-term memory deficits in 6-OHDA-lesioned rats.
    Matheus FC; Rial D; Real JI; Lemos C; Ben J; Guaita GO; Pita IR; Sequeira AC; Pereira FC; Walz R; Takahashi RN; Bertoglio LJ; Da Cunha C; Cunha RA; Prediger RD
    Behav Brain Res; 2016 Mar; 301():43-54. PubMed ID: 26707254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice.
    Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR
    Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease.
    Ciobica A; Olteanu Z; Padurariu M; Hritcu L
    J Physiol Biochem; 2012 Mar; 68(1):59-69. PubMed ID: 22006204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.
    Santiago RM; Tonin FS; Barbiero J; Zaminelli T; Boschen SL; Andreatini R; Da Cunha C; Lima MM; Vital MA
    Neuroscience; 2015 Aug; 300():246-53. PubMed ID: 25999296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat.
    Yang J; Song S; Li J; Liang T
    Pathol Res Pract; 2014 Jun; 210(6):357-62. PubMed ID: 24642369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arbutus andrachne L. Reverses Sleep Deprivation-Induced Memory Impairments in Rats.
    Alzoubi KH; Malkawi BS; Khabour OF; El-Elimat T; Alali FQ
    Mol Neurobiol; 2018 Feb; 55(2):1150-1156. PubMed ID: 28101814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
    Kopalli SR; Noh SJ; Koppula S; Suh YH
    Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment with L-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease.
    Chiu WH; Depboylu C; Hermanns G; Maurer L; Windolph A; Oertel WH; Ries V; Höglinger GU
    Neuropharmacology; 2015 Aug; 95():367-76. PubMed ID: 25839898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide Mitigates Impairments in Mitochondrial Function and Bioenergetics with α-Synuclein Pathology in 6-OHDA-Induced Hemiparkinson's Model in Rats.
    Mishra A; Krishnamurthy S
    Neurotox Res; 2019 Apr; 35(3):542-562. PubMed ID: 30610666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial memory deficits and oxidative stress damage following exposure to lipopolysaccharide in a rodent model of Parkinson's disease.
    Hritcu L; Ciobica A; Stefan M; Mihasan M; Palamiuc L; Nabeshima T
    Neurosci Res; 2011 Sep; 71(1):35-43. PubMed ID: 21663772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model.
    Jindal A; Mahesh R; Bhatt S; Pandey D
    Neurochem Int; 2017 Dec; 111():3-11. PubMed ID: 27988361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.
    Jindal A; Mahesh R; Bhatt S
    Psychopharmacology (Berl); 2015 Feb; 232(3):623-37. PubMed ID: 25120105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Fragment C Domain of Tetanus Toxin and Pramipexole in an Animal Model of Parkinson's Disease.
    Patricio F; Parra I; Martínez I; Pérez-Severiano F; Montes S; Aguilera J; Limón ID; Tizabi Y; Mendieta L
    Neurotox Res; 2019 Apr; 35(3):699-710. PubMed ID: 30607904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.